Breast Cancer Research and Treatment provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a "market place" for breast cancer topics which cuts ...
In the era of targeted therapies and immunotherapy for cancer, the focus in breast cancer (BC) research has shifted away from classical chemotherapy. Many BC patients, however, still need chemotherapy and thus benefit from the development of new chemotherapeutic agents or regimens. In the past ...
Manage bodily fluids and waste that may have traces of chemo. Usually, this means flushing the toilet twice. You’ll see your doctor every four to six months for the next five years after treatment ends. How to Recognize a Cancer Emergency ...
Chemotherapy is a medical treatment that is used to treat cancer using anti-cancer drugs. The drugs administered inhibit mitosis, or cell division of the cancer cells. One of the side affects is often hair loss, because the drugs usually also impact normal, healthy, fast-dividing cells, such...
There are several lines of defense when it comes to treating breast cancer. Chemotherapy is one of them.
This matched cohort study compares time to cancer treatment initiation and relative dose intensity of neoadjuvant and adjuvant chemotherapy among patients
Progress in the treatment of breast cancer developed along multiple directions of research during the last decade. The concept of dose-intensity was addressed through retrospective analyses and prospective randomized trials. It was confirmed that dose-intensity correlates with higher response rates, but ...
Metaplastic breast cancer is a highly chemoresistant breast cancer subtype with limited therapeutic options. Here, the authors report that the NOS inhibitor, L-NMMA, sensitises metaplastic breast cancer to a selective PI3K inhibitor, alpelisib, and taxane chemotherapy via repression of c-JUN mediated...
A new study adds to the evidence that chemotherapy enhances cancer's spread beyond the primary tumor, showing how one chemo drug allows breast cancer cells to squeeze through and attach to blood vessel linings in the lungs.
Those who declined did so either because they could not spare the time or because they were not involved in the treatment of patients with advanced breast cancer. All participating clini- cians were currently involved in the treatment of women with advanced breast cancer. The participants ...